PD-1, another immune checkpoint, is widely expressed on activated anti-tumor immune cells, including T and natural killer (NK) cells, and APCs, and yields inhibitory signals through binding of its two ligands, namely PD-L1 and PD-L2 (86). Here, PDCD1 is linked to neoplasm.